UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Clinical cancer research, 2016-11, Vol.22 (22), p.5461-5471

2016

Volltextzugriff (PDF)

Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

The lancet oncology, 2013-11, Vol.14 (12), p.1233-1242

2013

Volltextzugriff (PDF)

A systematic review of the efficacy and safety experience reported for sorafenib in advanced renal cell carcinoma (RCC) in the post-approval setting

PloS one, 2015-04, Vol.10 (4), p.e0120877

2015

Volltextzugriff (PDF)

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.49-7, Article 49

2019

Volltextzugriff (PDF)

Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison

Supportive care in cancer, 2016-10, Vol.24 (10), p.4159-4166

2016

Volltextzugriff (PDF)

Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer

Oncoimmunology, 2018-09, Vol.7 (9), p.e1476816-e1476816

2018

Volltextzugriff (PDF)

Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial

The lancet oncology, 2018-03, Vol.19 (3), p.405-415

2018

Volltextzugriff (PDF)

Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma

Journal of vascular and interventional radiology, 2017-02, Vol.28 (2), p.254-259

2017

Volltextzugriff (PDF)

Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison

The Journal of urology, 2015-09, Vol.194 (3), p.690-695

2015

Volltextzugriff (PDF)

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study

JAMA oncology, 2017-09, Vol.3 (9), p.e172411

2017

Volltextzugriff (PDF)

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

European urology, 2021-08, Vol.80 (2), p.162-170

2021

Volltextzugriff (PDF)

Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2021-2027

2015

Volltextzugriff (PDF)

Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma

Targeted oncology, 2017-06, Vol.12 (3), p.333-340

2017

Volltextzugriff (PDF)

Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial

European journal of cancer (1990), 2021-03, Vol.145, p.1-10

2021

Volltextzugriff (PDF)

Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer

Cancer, 2017-12, Vol.123 (23), p.4566-4573

2017

Volltextzugriff (PDF)

Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia

Cancer, 2018-02, Vol.124 (3), p.499-506

2018

Volltextzugriff (PDF)

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Clinical cancer research, 2020-11, Vol.26 (21), p.5598-5608

2020

Volltextzugriff (PDF)

Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison

Psycho-oncology (Chichester, England), 2018-01, Vol.27 (1), p.316-324

2018

Volltextzugriff (PDF)

Clinical scenarios for neoadjuvant chemotherapy of squamous penile cancer that is clinically node positive

Translational andrology and urology, 2017-10, Vol.6 (5), p.839-847

Fishman, Mayer N

2017

Volltextzugriff (PDF)

Targeted therapy of kidney cancer: keeping the art around the algorithms

Cancer control, 2013-07, Vol.20 (3), p.222-232

Fishman, Mayer N

2013

Volltextzugriff (PDF)

Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study

Cardiovascular and interventional radiology, 2021-11, Vol.44 (11), p.1755-1762

2021

Volltextzugriff (PDF)

Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison

Supportive care in cancer, 2016-05, Vol.24 (5), p.2201-2207

2016

Volltextzugriff (PDF)

Phase I Trial of ALT-801, an Interleukin-2/T-Cell Receptor Fusion Protein Targeting p53 (aa264―272)/HLA-A0201 Complex, in Patients with Advanced Malignancies

Clinical cancer research, 2011-12, Vol.17 (24), p.7765-7775

2011

Volltextzugriff (PDF)

Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma

Clinical genitourinary cancer, 2016-12, Vol.14 (6), p.499-503

2016

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(99)
Buchkapitel
(2)

Sprache

Englisch
(101)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(39)
Oncology
(31)
Male
(28)
Aged
(21)
Middle Aged
(20)
Female
(18)
Renal Cell Carcinoma
(16)
Adult
(14)
Treatment Outcome
(13)
Carcinoma, Renal Cell - Drug Therapy
(12)
Kidney Cancer
(12)
Kidney Neoplasms - Drug Therapy
(12)
Kidney Neoplasms - Pathology
(12)
Neoplasm Staging
(11)
Cancer
(10)
Immunotherapy
(10)
Aged, 80 And Over
(9)
Carcinoma, Renal Cell - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

A systematic review of the efficacy and safety experience reported for sorafenib in advanced renal cell carcinoma (RCC) in the post-approval setting

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison

Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer

Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial

Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma

Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison

Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma

Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)

Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial

Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer

Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia

Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma

Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison

Clinical scenarios for neoadjuvant chemotherapy of squamous penile cancer that is clinically node positive

Targeted therapy of kidney cancer: keeping the art around the algorithms

Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study

Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison

Phase I Trial of ALT-801, an Interleukin-2/T-Cell Receptor Fusion Protein Targeting p53 (aa264―272)/HLA-A0201 Complex, in Patients with Advanced Malignancies

Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma

Suchergebnisse filtern